United States · FDA National Drug Code directory

Talzenna

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63539-295_245347ef-49f2-4b24-9892-b43489562a46
Product NDC
63539-295
Form
CAPSULE
Composition / generic term
talazoparib
Labeler
U.S. Pharmaceuticals
Marketing category
NDA
Marketing start / end (source format)
20181210 / 20270131

Source-listed ingredients

  • TALAZOPARIB TOSYLATE — 1 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 1 BOTTLE in 1 CARTON (63539-295-30) / 30 CAPSULE in 1 BOTTLE · 63539-295-30

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →